Jeffrey W. Sherman, Director at Xeris Biopharma Holdings, Inc. (XERS), bought 5,400 shares at $1.87 ($10K) on 2023-11-27, disclosed to the SEC on 2023-11-29.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| HZNP | SELL | 2023-01-12 | $1.5M | — | Filing → |
| HZNP | SELL | 2023-01-06 | $1.2M | — | Filing → |
| HZNP | SELL | 2022-12-13 | $6.3M | — | Filing → |